PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

The present invention provides compounds of Formula I , including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for...

Full description

Saved in:
Bibliographic Details
Main Authors KALLAN, NICHOLAS, C, CHABOT, CHRISTINE, XU, RUI, BENCSIK, JOSEF, R, MITCHELL, IAN, S, SAFINA, BRIAN, S, BLAKE, JAMES, F, SPENCER, KEITH, L, LIANG, JUN, XIAO, DENGMING
Format Patent
LanguageEnglish
French
German
Published 14.04.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides compounds of Formula I , including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Bibliography:Application Number: EP20080781340